Works matching DE "ERYTHROPOIETIC protoporphyria"

Results: 98
    1
    2

    German Cohort Observational Study to Investigate the Short‐ and Long‐Term Safety and Clinical Effectiveness of Afamelanotide 16 mg (SCENESSE) in Patients With Erythropoietic Protoporphyria (EPP).

    Published in:
    Photodermatology, Photoimmunology & Photomedicine, 2025, v. 41, n. 2, p. 1, doi. 10.1111/phpp.13012
    By:
    • Homey, Bernhard;
    • Schelonke, Kathrin;
    • Schlegel, Carla Marie;
    • Bruch‐Gerharz, Daniela;
    • Weller, Karsten;
    • Kiefer, Lea;
    • Stölzel, Ulrich;
    • Staubach‐Renz, Petra;
    • Wegner, Joanna;
    • Keller‐Melchior, Regine;
    • Walker, Gillian;
    • Bochno, Malgorzata;
    • Bilbao, Pilar
    Publication type:
    Article
    3
    4

    Ultraviolet A phototest positivity is associated with higher free erythrocyte protoporphyrin IX concentration and lower transferrin saturation values in erythropoietic protoporphyria.

    Published in:
    Photodermatology, Photoimmunology & Photomedicine, 2022, v. 38, n. 2, p. 141, doi. 10.1111/phpp.12727
    By:
    • Genovese, Giovanni;
    • Maronese, Carlo Alberto;
    • Moltrasio, Chiara;
    • Piccinno, Roberta;
    • Marletta, Dario Antonio;
    • De Luca, Giacomo;
    • Graziadei, Giovanna;
    • Granata, Francesca;
    • Di Pierro, Elena;
    • Cappellini, Maria Domenica;
    • Marzano, Angelo Valerio
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12

    Erythematous patches on the hands.

    Published in:
    Journal of Family Practice, 2012, v. 61, n. 2, p. 101
    By:
    • Kasper, David A.;
    • Centilli, Michael;
    • Silverton, Kimball
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20

    Osteoporosis in patients with erythropoietic protoporphyria.

    Published in:
    British Journal of Dermatology, 2017, v. 177, n. 6, p. 1693, doi. 10.1111/bjd.15893
    By:
    • Biewenga, M.;
    • Matawlie, R. H. S.;
    • Friesema, E. C. H.;
    • Koole‐Lesuis, H.;
    • Langeveld, M.;
    • Wilson, J. H. P.;
    • Langendonk, J. G.
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Porphyrins and the porphyrias.

    Published in:
    Liver International, 2025, v. 45, n. 3, p. 1, doi. 10.1111/liv.16061
    By:
    • Fontanellas, Antonio;
    • Avila, Matías A.;
    • Deybach, Jean‐Charles;
    • Badminton, Michael N.
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41

    Microcytosis in Erythropoietic Protoporphyria.

    Published in:
    Frontiers in Physiology, 2022, v. 13, p. 1, doi. 10.3389/fphys.2022.841050
    By:
    • Graziadei, Giovanna;
    • Duca, Lorena;
    • Granata, Francesca;
    • De Luca, Giacomo;
    • De Giovanni, Anna;
    • Brancaleoni, Valentina;
    • Nava, Isabella;
    • Di Pierro, Elena
    Publication type:
    Article
    42
    43
    44

    Role of phlebotomy in the treatment of liver damage related to erythropoietic porphyria.

    Published in:
    Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-10089-z
    By:
    • Hagiwara, Satoru;
    • Nishida, Naoshi;
    • Ida, Hiroshi;
    • Ueshima, Kazuomi;
    • Minami, Yasunori;
    • Takita, Masahiro;
    • Aoki, Tomoko;
    • Morita, Masahiro;
    • Chishina, Hirokazu;
    • Komeda, Yoriaki;
    • Yoshida, Akihiro;
    • Park, Ah-Mee;
    • Sato, Masako;
    • Kawada, Akira;
    • Nakano, Hajime;
    • Nakagawa, Hiroshi;
    • Kudo, Masatoshi
    Publication type:
    Article
    45
    46
    47
    48
    49

    Highlights.

    Published in:
    Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 2, p. 252, doi. 10.1002/cpt.2961
    Publication type:
    Article
    50